Biblio
PRDX1 negatively regulates bleomycin-induced pulmonary fibrosis via inhibiting the epithelial-mesenchymal transition and lung fibroblast proliferation in vitro and in vivo. Cell Mol Biol Lett. 2023;28(1):48.
Peroxiredoxin II with dermal mesenchymal stem cells accelerates wound healing. Aging (Albany NY). 2021;13.
. Peroxiredoxin II regulates exosome secretion from dermal mesenchymal stem cells through the ISGylation signaling pathway. Cell Commun Signal. 2023;21(1):296.
Peroxiredoxin I and II as novel therapeutic molecular targets in cervical cancer treatment through regulation of endoplasmic reticulum stress induced by bleomycin. Cell Death Discov. 2024;10(1):267.
. . .